Major pharmacy companies agree to settle in nationwide opioid cases
CVS and Walgreens, two of the largest pharmacy chains in the country, have agreed to pay $5 billion each to settle lawsuits throughout the country over allegations of mishandling opioid prescriptions. The companies announced the settlement plan through government filings but need the approval of the myriad of plaintiffs before the deal can go into effect, The New York Times reports.
These settlements can potentially put an end to the decades of lawsuits regarding the role of the drug industry in the opioid epidemic, NPR reports. Opioid overdose was the cause of 80,000 deaths in 2021 alone and approximately 9.5 million Americans reported misusing opioids in 2020, according to CNN. Opioids are painkillers that can be illegal, like heroin, or prescribed by doctors, including morphine, oxycodone, and hydrocodone.
Previously, the companies tried fighting the lawsuits in court; they were unsuccessful, however, when a federal judge ordered them to pay $650 million to two Ohio counties in August, the Times continues. The jury explained that the companies seemed to turn a blind eye to alarming pill quantities and continued to dispense.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
CVS and Walgreens have specified that their willingness to pay settlements does not equate to an admission of wrongdoing. Along with CVS and Walgreens, Walmart has agreed to pay $3 billion in settlements as well.
CVS general counsel Thomas Moriarty said in a statement, "We are committed to working with states, municipalities, and tribes, and will continue our own important initiatives to help reduce the illegitimate use of prescription opioids."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
The decline of the contraceptive pill
In the Spotlight Fears of the pill's side effects, stoked by social media, behind switch to fertility trackers – or no contraception at all
By Harriet Marsden, The Week UK Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Kidney stones are affecting children far more than they once did
Under the radar Salt may be to blame
By Devika Rao, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Walking pneumonia cases are picking up pace
The explainer Another respiratory illness to be wary of
By Devika Rao, The Week US Published
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published